Login / Signup

Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?

Medhat M SaidMartinus P G BroenEleonora L SwartImke H BartelinkMathilde C M Kouwenhoven
Published in: Cancers (2023)
Glioblastoma multiforme is the most common primary central nervous system tumor, with an incidence of 3 [...].
Keyphrases
  • risk factors
  • cerebrospinal fluid
  • newly diagnosed